FdaApplication

ANDA 211032

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2020-01-31

Products (1)

ProductActive ingredientStrengthDosage form
CLOBAZAMCLOBAZAM2.5MG/MLSUSPENSION;ORAL

1 product